Article
Efficacy and safety of sirolimus therapy in familial hypoinsulinemic hypoglycemia caused by AKT2 mutation inherited from the mosaic father.
European journal of medical genetics - 1 Dec 2021
Dushar Marya, Nowaczyk Jędrzej, Pyrżak Beata, Akopyan Hayane, Śmigiel Robert, Walczak Anna, Rydzanicz Małgorzata, Płoski Rafał, Szczałuba Krzysztof
Abstract excerpt
Activating mutation in the insulin signal-transducing kinase AKT2 results in severe hypoinsulinemic hypoketotic hypoglycemia and a characteristic phenotype of possible overgrowth and, sometimes, acanthosis nigricans. Herein, we describe a metabolic and hormonal profile before and during treatment with sirolimus in two brothers with AKT2 mutation inherited from the mosaic father, who showed low-level mosaicism in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
